Mitsubishi UFJ Asset Management’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$56.9M Buy
268,354
+16,913
+7% +$3.32M 0.03% 386
2026
Q1
$49.3M Buy
251,441
+22,031
+10% +$4.28M 0.03% 377
2025
Q4
$39.9M Buy
229,410
+5,038
+2% +$917K 0.03% 416
2025
Q3
$42.8M Buy
224,372
+8,269
+4% +$1.47M 0.03% 391
2025
Q2
$38.8M Buy
216,103
+18,268
+9% +$3.17M 0.03% 398
2025
Q1
$33.5M Buy
197,835
+20,446
+12% +$3.36M 0.03% 400
2024
Q4
$26.9M Buy
177,389
+8,665
+5% +$1.35M 0.03% 435
2024
Q3
$26.2M Buy
168,724
+16,762
+11% +$2.5M 0.03% 426
2024
Q2
$20.8M Buy
151,962
+20,633
+16% +$2.83M 0.03% 442
2024
Q1
$17.5M Buy
131,329
+18,642
+17% +$2.42M 0.02% 464
2023
Q4
$15.7M Buy
112,687
+138
+0.1% +$18.1K 0.03% 437
2023
Q3
$13.7M Buy
112,549
+14,646
+15% +$1.95M 0.03% 434
2023
Q2
$13.8M Buy
97,903
+2,491
+3% +$343K 0.03% 425
2023
Q1
$13.5M Buy
95,412
+8,528
+10% +$1.22M 0.03% 399
2022
Q4
$13.5M Buy
86,884
+6,224
+8% +$894K 0.04% 374
2022
Q3
$9.9M Buy
80,660
+12,012
+17% +$1.58M 0.03% 406
2022
Q2
$9.13M Buy
68,648
+4,363
+7% +$595K 0.04% 411
2022
Q1
$8.8M Buy
64,285
+1,690
+3% +$236K 0.03% 453
2021
Q4
$10.3M Buy
62,595
+8,529
+16% +$1.3M 0.04% 424
2021
Q3
$7.86M Buy
54,066
+4,384
+9% +$641K 0.04% 459
2021
Q2
$6.56M Buy
49,682
+6,454
+15% +$845K 0.04% 494
2021
Q1
$5.55M Buy
43,228
+3,823
+10% +$471K 0.04% 480
2020
Q4
$4.7M Buy
39,405
+2,375
+6% +$290K 0.04% 460
2020
Q3
$4.24M Buy
37,030
+6,366
+21% +$752K 0.04% 418
2020
Q2
$3.49M Buy
30,664
+4,432
+17% +$470K 0.04% 405
2020
Q1
$2.11M Sell
26,232
-1,035
-4% -$107K 0.03% 442
2019
Q4
$2.87M Buy
27,267
+3,897
+17% +$406K 0.04% 436
2019
Q3
$2.5M Buy
23,370
+839
+4% +$86.1K 0.04% 402
2019
Q2
$2.29M Buy
22,531
+4,035
+22% +$388K 0.04% 423
2019
Q1
$1.66M Buy
18,496
+1,361
+8% +$118K 0.03% 452
2018
Q4
$1.38M Sell
17,135
-1,616
-9% -$152K 0.03% 442
2018
Q3
$2.02M Buy
18,751
+329
+2% +$36.1K 0.04% 409
2018
Q2
$2.02M Sell
18,422
-413
-2% -$43K 0.04% 392
2018
Q1
$1.89M Sell
18,835
-2,097
-10% -$215K 0.04% 407
2017
Q4
$2.08M Sell
20,932
-20
-0.1% -$1.9K 0.05% 403
2017
Q3
$1.96M Buy
20,952
+1,193
+6% +$127K 0.05% 399
2017
Q2
$2.2M Sell
19,759
-2,560
-11% -$271K 0.05% 360
2017
Q1
$2.19M Buy
22,319
+794
+4% +$75.7K 0.05% 382
2016
Q4
$1.99M Sell
21,525
-83
-0.4% -$7.15K 0.05% 392
2016
Q3
$1.83M Buy
21,608
+297
+1% +$24.9K 0.05% 404
2016
Q2
$1.74M Buy
21,311
+411
+2% +$31.3K 0.05% 400
2016
Q1
$1.49M Buy
20,900
+1,827
+10% +$123K 0.04% 424
2015
Q4
$1.36M Buy
19,073
+1,089
+6% +$73.2K 0.04% 438
2015
Q3
$1.1M Sell
17,984
-230
-1% -$16.1K 0.03% 482
2015
Q2
$1.32M Sell
18,214
-1,158
-6% -$85.5K 0.04% 459
2015
Q1
$1.49M Sell
19,372
-1,033
-5% -$74K 0.04% 447
2014
Q4
$1.41M Sell
20,405
-2,815
-12% -$178K 0.04% 445
2014
Q3
$1.41M Sell
23,220
-4,981
-18% -$307K 0.04% 455
2014
Q2
$1.66M Buy
28,201
+88
+0.3% +$5.15K 0.04% 446
2014
Q1
$1.63M Sell
28,113
-50
-0.2% -$2.68K 0.04% 444
2013
Q4
$1.49M Sell
28,163
-8,073
-22% -$479K 0.04% 463
2013
Q3
$2.24M Buy
36,236
+2,236
+7% +$134K 0.06% 366
2013
Q2
$2.06M Buy
+34,000
New +$2.03M 0.06% 372

Other funds holding DGX

Mitsubishi UFJ Asset Management's DGX Position: Q2 2026 in Review

Mitsubishi UFJ Asset Management increased its Quest Diagnostics (DGX) stake by 6.7% in Q2 2026, buying an estimated $3.32M and bringing the position to 268,354 shares worth $56.9M. The position accounts for 0.03% of the portfolio, ranked #386.

Mitsubishi UFJ Asset Management first reported a position in DGX in Q2 2013 and has held it in 53 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Mitsubishi UFJ Asset Management held 268,354 shares of Quest Diagnostics worth $56.9M as of Q2 2026.
  • Mitsubishi UFJ Asset Management bought 16,913 Quest Diagnostics shares in Q2 2026, an estimated $3.32M.
  • Quest Diagnostics made up 0.03% of Mitsubishi UFJ Asset Management's portfolio in Q2 2026, its #386 holding.
  • Mitsubishi UFJ Asset Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 53 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Mitsubishi UFJ Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.